Related Experiment Video
Updated: Aug 15, 2026

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Acquired Glanzmann's thrombasthenia associated with acute lymphoblastic leukemia
Jean-Marie André1, Claire Galambrun, Marie-Christine Trzeciak
1Hospices Civils de Lyon, Hôpital Debrousse, Service d'Onco-Hématologie Pédiatrique, Lyon, France. eli.jm@club-internet.fr
Abstract:
Acquired Glanzmann's thrombasthenia is an uncommon event in association with leukemia. The authors describe a patient with acute lymphoblastic leukemia (ALL) who presented with severe hemorrhagic syndrome, without disseminated intravascular coagulation. The patient's course was complicated by the occurrence of severe hemorrhagic episodes, with a thrombasthenia-like profile, requiring multiple transfusions with packed red cells, platelets, and fresh-frozen plasma. Biological explorations detected anti-GPIIb/IIIa complex antibodies. The patient finally died with refractory disease and persistent bleeding. This case is the first reported of autoantibodies to GPIIb/IIIa in ALL. Such paraneoplastic syndrome is potentially responsible for severe life-threatening hemorrhage.
